| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
and Granulocyte-Macrophage Colony-Stimulating Factor1
*
Department of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; and
David R. Bloom Center of Pharmacy
Mast cell-eosinophil interactions in allergy have not yet been
completely defined. To determine whether mast cells influence
eosinophil survival, human peripheral blood eosinophils were incubated
with rat peritoneal mast cell sonicate. After 3 days, viable
eosinophils in medium were 21.3% compared with 44% with mast cell
sonicate. Like sonicate, supernatants of compound 48/80-activated mast
cells enhanced eosinophil survival, demonstrating that the factor(s)
involved is stored preformed and rapidly released. Increased eosinophil
survival was due to an inhibition of apoptosis (morphologic analysis;
annexin V/PI). Neutralizing Abs to granulocyte-macrophage CSF (GM-CSF),
but not to IL-3 or IL-5, decreased by 61.7% the enhancing effect on
eosinophil viability. Eosinophils are the source of GM-CSF since its
release in the culture medium was inhibited by their incubation with
the mast cell sonicate together with dexamethasone. In addition,
eosinophils incubated with the sonicate expressed mRNA for GM-CSF. To
partially characterize the mast cell-derived factor(s) increasing
eosinophil survival, the sonicate was heated (56°C/30 min or
100°C/10 min) or preincubated with antihistamines or with
anti-TNF-
-neutralizing Abs. Most of the activity was heat
labile. TNF- was found to be predominantly (70%) responsible, while
histamine had no role. Mast cell sonicate also caused eosinophils to
release eosinophil peroxidase and to display morphologic signs of
activation. In conclusion, we have demonstrated that mast cells enhance
eosinophil survival in part through their activation to produce and
release the autocrine survival cytokine GM-CSF.
This article has been cited by other articles:
|
|
 |
|
  B. L. Bennett c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur. Respir. J., September 1, 2006; 28(3): 651 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kinoshita, M. Okada, M. Hara, Y. Furukawa, and A. Matsumori Mast Cell Tryptase in Mast Cell Granules Enhances MCP-1 and Interleukin-8 Production in Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1858 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Steffel, A. Akhmedov, H. Greutert, T. F. Luscher, and F. C. Tanner Histamine Induces Tissue Factor Expression: Implications for Acute Coronary Syndromes Circulation, July 19, 2005; 112(3): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsumoto, M. Terakawa, K. Miura, S. Fukuda, T. Nakajima, and H. Saito Extremely Rapid and Intense Induction of Apoptosis in Human Eosinophils by Anti-CD30 Antibody Treatment In Vitro J. Immunol., February 15, 2004; 172(4): 2186 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Esnault and J. S. Malter Hyaluronic Acid or TNF-{alpha} Plus Fibronectin Triggers Granulocyte Macrophage-Colony-Stimulating Factor mRNA Stabilization in Eosinophils Yet Engages Differential Intracellular Pathways and mRNA Binding Proteins J. Immunol., December 15, 2003; 171(12): 6780 - 6787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Raqib, P. K. Moly, P. Sarker, F. Qadri, N. H. Alam, M. Mathan, and J. Andersson Persistence of Mucosal Mast Cells and Eosinophils in Shigella-Infected Children Infect. Immun., May 1, 2003; 71(5): 2684 - 2692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Temkin, B. Kantor, V. Weg, M.-L. Hartman, and F. Levi-Schaffer Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release J. Immunol., September 1, 2002; 169(5): 2662 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Esnault and J. S. Malter Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils Blood, May 13, 2002; 99(11): 4048 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Capowski, S. Esnault, S. Bhattacharya, and J. S. Malter Y Box-Binding Factor Promotes Eosinophil Survival by Stabilizing Granulocyte-Macrophage Colony-Stimulating Factor mRNA J. Immunol., November 15, 2001; 167(10): 5970 - 5976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Esnault and J. S. Malter Granulocyte Macrophage-Colony-Stimulating Factor mRNA Is Stabilized in Airway Eosinophils and Peripheral Blood Eosinophils Activated by TNF-{{alpha}} Plus Fibronectin J. Immunol., April 1, 2001; 166(7): 4658 - 4663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Hartman, A. M. Piliponsky, V. Temkin, and F. Levi-Schaffer Human peripheral blood eosinophils express stem cell factor Blood, February 15, 2001; 97(4): 1086 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Saita, T. Yamanaka, H. Kohrogi, M. Ando, and M. Hirashima Apoptotic response of eosinophils in chronic eosinophilic pneumonia Eur. Respir. J., February 1, 2001; 17(2): 190 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-U. Simon, M. Weber, E. Becker, Y. Zilberman, K. Blaser, and F. Levi-Schaffer Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist J. Immunol., October 1, 2000; 165(7): 4069 - 4075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Levi-Schaffer, E. Garbuzenko, A. Rubin, R. Reich, D. Pickholz, P. Gillery, H. Emonard, A. Nagler, and F. A. X. Maquart Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor beta (TGF-beta ) PNAS, August 17, 1999; 96(17): 9660 - 9665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
